• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Circio Holding

Less than 1K followers

CRNA

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

Circio Holding is a pharmaceutical company. The company's specialist expertise is found in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the medicines are sold under separate brands. Several partnerships in the market have been entered into to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.

Read more
Market cap
-
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
31/8
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Press release2026-06-24 13:21

Analyst Group: Analyst Group Comment on Circio's Research Collaboration with Tcelltech

Circio Holding
Regulatory press release2026-06-24 07:00

Circio and Tcelltech jointly announce CAR-T cell therapy research collaboration

Circio Holding
Regulatory press release2026-06-22 14:05

Circio Holding ASA – Share capital increase registered

Circio Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-18 11:02

CIRCIO HOLDING ASA – SHARE CAPITAL INCREASE REGISTERED FOLLOWING EXERCISE OF WARRANTS AND UNDERWRITTEN PRIVATE PLACEMENT

Circio Holding
Press release2026-06-10 11:03

Analyst Group: Analyst Group Comment on Circio's NOK 300m Capital Raise

Circio Holding
Regulatory press release2026-06-09 23:12

Circio completes transformational fundraising of NOK 300 million to strengthen its position as the global leader in circular RNA-based gene expression systems

Circio Holding
Regulatory press release2026-06-09 07:00

Circio Holding ASA: Last day of the exercise period for the Warrants

Circio Holding
Regulatory press release2026-06-04 09:41

Circio Holding ASA – Exercise of Warrants by primary insiders

Circio Holding
Regulatory press release2026-06-03 07:00

Circio Holding ASA: Last day of trading in warrants

Circio Holding
Regulatory press release2026-06-02 10:33

Circio Holding ASA – Exercise of Warrants by primary insiders

Circio Holding
Press release2026-06-01 13:10

Analyst Group: Analyst Group Comment on Circio’s Research Collaboration with GenAssist

Circio Holding
Regulatory press release2026-06-01 07:00

CRNA: Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy

Circio Holding
Press release2026-06-01 07:00

Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy

Circio Holding
Regulatory press release2026-05-29 07:00

Circio Holding ASA – Exercise of Warrants by primary insiders

Circio Holding
Regulatory press release2026-05-28 07:00

Circio hosts live webcast today 28 May 2026 at 10:00 am CEST

Circio Holding
Press release2026-05-28 07:00

Circio hosts live webcast today 28 May 2026 at 10:00 am CEST

Circio Holding
Press release2026-05-27 14:50

Analyst Group: Analyst Group Comment on Circio’s Research Collaboration with AaviGen for Cardiac AAV Gene Therapy

Circio Holding
Regulatory press release2026-05-27 07:00

CRNA: Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases

Circio Holding
Press release2026-05-27 07:00

Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases

Circio Holding
Regulatory press release2026-05-26 07:10

Announcement of the terms of the underwriting and the Unused Warrants Option Agreement in connection with the Warrant Program

Circio Holding